机构

• 上海药物研究所 [8]
• 大连化学物理研究所 [2]

采集方式

• OAI收割 [10]

内容类型

• 期刊论文 [10]

发表日期

• 2024 [1]
• 2023 [2]
• 2022 [4]
• 2016 [1]
• 2015 [2]

学科主题

筛选

浏览/检索结果: 共10条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders 期刊论文  OAI收割 JOURNAL OF ADVANCED RESEARCH, 2024, 卷号: 63, 页码: 219-230 作者:  Chen, Shuqiang;  Bi, Kaijian;  Liang, Huixin;  Wu, Zhe;  Huang, Min   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/10/21 PROTAC  Natural products  Target identification  Quantitative proteomics  Antitumor activities   Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 24, 页码: 16694-16703 作者:  Fu, Yixian;  Huang, Yahui;  Zhou, Chenchen;  Li, Xinge;  Dong, Guoqiang   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/01/26 Stimuli-activatable PROTACs for precise protein degradation and cancer therapy 期刊论文  OAI收割 SCIENCE BULLETIN, 2023, 卷号: 68, 期号: 10, 页码: 1069-1085 作者:  Gao, Jing;  Yang, Lei;  Lei, Shumin;  Zhou, Feng;  Nie, Huijun   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/10/17 PROTAC  Stimuli-activatable prodrug  Precise protein degradation  Nanomedicine  Combinatory therapy   Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 页码: 15 作者:  Bi, Kaijian;  Cheng, Junfei;  He, Shipeng;  Fang, Yuxin;  Huang, Min   |  收藏  |  浏览/下载：26/0  |  提交时间：2023/04/10 Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 页码: 13 作者:  Cheng, Junfei;  He, Shipeng;  Xu, Jun;  Huang, Min;  Dong, Guoqiang   |  收藏  |  浏览/下载：16/0  |  提交时间：2023/04/10 NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 6, 页码: 2859-2868 作者:  Wu, Ying;  Pu, Congying;  Fu, Yixian;  Dong, Guoqiang;  Huang, Min   |  收藏  |  浏览/下载：10/0  |  提交时间：2024/03/21 NAMPT  Non-enzymatic function  eNAMPT  Cancer  MDSC  PROTAC  Tumor immunity  Immunotherapy   Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy br 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 6, 页码: 4818-4831 作者:  Wu, Shanchao;  Huang, Yahui;  Wang, Ting;  Li, Keliang;  Lu, Junjie   |  收藏  |  浏览/下载：57/0  |  提交时间：2022/08/16 Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 7, 页码: 3215-3230 作者:  Wang, Youxin;  Chen, Feifei;  Di, Hongxia;  Xu, Yong;  Xiao, Qiang   |  收藏  |  浏览/下载：15/0  |  提交时间：2019/01/08 ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling 期刊论文  OAI收割 Oncotarget, 2015, 卷号: 6, 期号: 13, 页码: 11627 作者:  Jin Ding;  Wen Wen;  Daimin Xiang;  Peipei Yin;  Liu YF(刘艳芳) 收藏  |  浏览/下载：21/0  |  提交时间：2016/11/24 psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling 期刊论文  OAI收割 oncotarget, 2015, 卷号: 6, 期号: 13, 页码: 11627-11639 作者:  Ding, Jin;  Wen, Wen;  Xiang, Daimin;  Yin, Peipei;  Liu, Yanfang 收藏  |  浏览/下载：59/0  |  提交时间：2015/11/17 psi-Bufarenogin  hepatocellular carcinoma  epithelial growth factor receptor  hepatocyte growth factor receptor